Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. - ROEverified

ICPT

Price:

$19

Market Cap:

$794.69M

Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is p...[Read more]

Industry

Biotechnology

IPO Date

2012-10-11

Stock Exchange

NASDAQ

Ticker

ICPT

The ROE as of June 2026 (TTM) for Intercept Pharmaceuticals, Inc. (ICPT) is -253.45%

According to Intercept Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -253.45%. This represents a change of 1.19% compared to the average of -19.62% of the last 4 quarters.

Intercept Pharmaceuticals, Inc. (ICPT) Historical ROE (quarterly & annually)

How has ICPT ROE performed in the past?

The mean historical ROE of Intercept Pharmaceuticals, Inc. over the last ten years is -455.10%. The current -253.45% ROE has changed -44.31% with respect to the historical average. Over the past ten years (40 quarters), ICPT's ROE was at its highest in in the March 2020 quarter at 267.82%. The ROE was at its lowest in in the December 2017 quarter at -679.07%.

Quarterly (TTM)
Annual

Average

-455.10%

Median

-102.47%

Minimum

-2199.24%

Maximum

194.32%

Intercept Pharmaceuticals, Inc. (ICPT) ROE by Quarter and Year

Discovering the peaks and valleys of Intercept Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.58%

Maximum Annual ROE = 194.32%

Minimum Annual Increase = -125.62%

Minimum Annual ROE = -2199.24%

Quarterly (TTM)
Annual
YearROEChange
2022123.74%56.97%
202178.83%-59.43%
2020194.32%-125.62%
2019-758.50%-53.08%
2018-1616.53%-26.50%
2017-2199.24%1.58%
2016-131.09%248.60%
2015-37.60%-69.34%
2014-122.67%49.11%
2013-82.27%24.24%

Intercept Pharmaceuticals, Inc. (ICPT) Average ROE

How has ICPT ROE performed in the past?

The current ROE of Intercept Pharmaceuticals, Inc. (ICPT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

132.30%

5-year avg

-395.63%

10-year avg

-455.10%

Intercept Pharmaceuticals, Inc. (ICPT) ROE vs. Peers

How is ICPT’s ROE compared to its peers?

Intercept Pharmaceuticals, Inc.’s ROE is greater than Chimerix, Inc. (-56.17%), greater than Avid Bioservices, Inc. (-112.44%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than Icosavax, Inc. (-35.64%), less than ASLAN Pharmaceuticals Limited (1.80%), greater than Poseida Therapeutics, Inc. (-84.75%), greater than Albireo Pharma, Inc. (-84.83%), greater than Ikena Oncology, Inc. (-35.20%), greater than Gracell Biotechnologies Inc. (-37.93%), greater than Exscientia plc (-38.96%),

Build a custom stock screener for Intercept Pharmaceuticals, Inc. (ICPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intercept Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intercept Pharmaceuticals, Inc. (ICPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intercept Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Intercept Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the highest ROE for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the 3-year average ROE for Intercept Pharmaceuticals, Inc. (ICPT)?

What is the 5-year average ROE for Intercept Pharmaceuticals, Inc. (ICPT)?

How does the current ROE for Intercept Pharmaceuticals, Inc. (ICPT) compare to its historical average?